{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T20:22:37Z","timestamp":1793737357867,"version":"4.6.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001171","name":"Cancer Institute NSW","doi-asserted-by":"crossref","award":["TPG2165"],"award-info":[{"award-number":["TPG2165"]}],"id":[{"id":"10.13039\/501100001171","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001171","name":"Cancer Institute NSW","doi-asserted-by":"crossref","award":["TPG2165"],"award-info":[{"award-number":["TPG2165"]}],"id":[{"id":"10.13039\/501100001171","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"crossref","award":["1194004"],"award-info":[{"award-number":["1194004"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"crossref","award":["1194004"],"award-info":[{"award-number":["1194004"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"crossref","award":["2017140"],"award-info":[{"award-number":["2017140"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Detecting glioblastoma infiltration in the brain is challenging due to limited MRI contrast beyond the enhancing tumour core. This study aims to investigate the potential of superparamagnetic iron oxide nanoparticles (SPIONs) as contrast agents for improved detection of diffuse brain cancer. We examine the distribution and pharmacokinetics of SPIONs in glioblastoma models with intact and disrupted blood-brain barriers. Using MRI, we imaged RN1-luc and U87MG mice injected with Gadovist and SPIONs, observing differences in blood-brain barrier permeability. Peripheral imaging showed strong uptake of nanoparticles in the liver and spleen, while vascular and renal signals were transient. Susceptibility gradient mapping enabled positive nanoparticle contrast within tumours and provided additional information on tumour angiogenesis. This approach offers a novel method for detecting diffuse brain cancer. Our findings demonstrate that SPIONs enhance glioblastoma detection beyond conventional MRI, providing insights into tumour angiogenesis and opening new avenues for early diagnosis and targeted treatment strategies.<\/jats:p>","DOI":"10.1038\/s41598-025-97943-y","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T06:21:13Z","timestamp":1745475673000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Enhanced detection of glioblastoma vasculature with superparamagnetic iron oxide nanoparticles and MRI"],"prefix":"10.1038","volume":"15","author":[{"given":"Phillip W.","family":"Janowicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Boele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard T.","family":"Maschmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaser H.","family":"Gholami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma G.","family":"Kempe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett W.","family":"Stringer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihani P.","family":"Stoner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taymin","family":"du Toit-Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fern","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aude","family":"Touffu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenka","family":"Munoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zdenka","family":"Kuncic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Brighi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E. J.","family":"Waddington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,24]]},"reference":[{"key":"97943_CR1","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1148\/radiol.2018180200","volume":"289","author":"S Bae","year":"2018","unstructured":"Bae, S. et al. Radiomic MRI phenotyping of glioblastoma: improving survival prediction. Radiology 289, 797\u2013806 (2018).","journal-title":"Radiology"},{"key":"97943_CR2","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1093\/neuonc\/nox175","volume":"20","author":"JN Sarkaria","year":"2018","unstructured":"Sarkaria, J. N. et al. Is the blood\u2013brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data. Neuro-oncology 20, 184\u2013191 (2018).","journal-title":"Neuro-oncology"},{"key":"97943_CR3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41568-019-0205-x","volume":"20","author":"CD Arvanitis","year":"2020","unstructured":"Arvanitis, C. D., Ferraro, G. B. & Jain, R. K. The blood\u2013brain barrier and blood\u2013tumour barrier in brain tumours and metastases. Nat. Rev. Cancer. 20, 26\u201341 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"97943_CR4","doi-asserted-by":"crossref","unstructured":"Wirsching, H.-G., Galanis, E., & Weller, M. Glioblastoma. Handb. Clin. Neurol. 134, 381\u2013397 (2016).","DOI":"10.1016\/B978-0-12-802997-8.00023-2"},{"key":"97943_CR5","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00401-007-0293-7","volume":"114","author":"A Claes","year":"2007","unstructured":"Claes, A., Idema, A. J. & Wesseling, P. Diffuse glioma growth: a guerilla war. Acta Neuropathol. 114, 443\u2013458 (2007).","journal-title":"Acta Neuropathol."},{"key":"97943_CR6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s10014-010-0275-7","volume":"27","author":"T Yamahara","year":"2010","unstructured":"Yamahara, T. et al. Morphological and flow cytometric analysis of cell infiltration in glioblastoma: a comparison of autopsy brain and neuroimaging. Brain Tumor Pathol. 27, 81\u201387 (2010).","journal-title":"Brain Tumor Pathol."},{"key":"97943_CR7","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1039\/C8CS00805A","volume":"48","author":"W Tang","year":"2019","unstructured":"Tang, W. et al. Emerging blood\u2013brain-barrier-crossing nanotechnology for brain cancer theranostics. Chem. Soc. Rev. 48, 2967\u20133014 (2019).","journal-title":"Chem. Soc. Rev."},{"key":"97943_CR8","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1148\/radiol.2017162759","volume":"284","author":"HE Daldrup-Link","year":"2017","unstructured":"Daldrup-Link, H. E. Ten things you might not know about iron oxide nanoparticles. Radiology 284, 616\u2013629 (2017).","journal-title":"Radiology"},{"key":"97943_CR9","doi-asserted-by":"crossref","unstructured":"Gholami, Y. H. et al. A radio-nano-platform for T1\/T2 dual-mode PET-MR imaging. Int. J. Nanomed. 15, 1253\u20131266 (2020).","DOI":"10.2147\/IJN.S241971"},{"key":"97943_CR10","doi-asserted-by":"publisher","first-page":"7808","DOI":"10.1039\/C6NR00147E","volume":"8","author":"H Liu","year":"2016","unstructured":"Liu, H. et al. Application of iron oxide nanoparticles in glioma imaging and therapy: from bench to bedside. Nanoscale 8, 7808\u20137826 (2016).","journal-title":"Nanoscale"},{"key":"97943_CR11","doi-asserted-by":"publisher","first-page":"7816","DOI":"10.1039\/c3cs60149h","volume":"42","author":"J Gallo","year":"2013","unstructured":"Gallo, J., Long, N. J. & Aboagye, E. O. Magnetic nanoparticles as contrast agents in the diagnosis and treatment of cancer. Chem. Soc. Rev. 42, 7816\u20137833 (2013).","journal-title":"Chem. Soc. Rev."},{"key":"97943_CR12","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1039\/C1CS15248C","volume":"41","author":"N Lee","year":"2012","unstructured":"Lee, N. & Hyeon, T. Designed synthesis of uniformly sized iron oxide nanoparticles for efficient magnetic resonance imaging contrast agents. Chem. Soc. Rev. 41, 2575\u20132589 (2012).","journal-title":"Chem. Soc. Rev."},{"key":"97943_CR13","doi-asserted-by":"publisher","first-page":"4501","DOI":"10.1039\/C4CS00345D","volume":"44","author":"TH Shin","year":"2015","unstructured":"Shin, T. H., Choi, Y., Kim, S. & Cheon, J. Recent advances in magnetic nanoparticle-based multi-modal imaging. Chem. Soc. Rev. 44, 4501\u20134516 (2015).","journal-title":"Chem. Soc. Rev."},{"key":"97943_CR14","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1007\/s00330-023-10281-3","volume":"34","author":"AJ van der Molen","year":"2024","unstructured":"van der Molen, A. J., Quattrocchi, C. C., Mallio, C. A., Dekkers, I. A., European Society of Magnetic Resonance in Medicine. & B. G. R. Ten years of gadolinium retention and deposition: ESMRMB-GREC looks backward and forward. Eur. Radiol. 34, 600\u2013611 (2024). Educational Committee.","journal-title":"Eur. Radiol."},{"key":"97943_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11604-015-0503-5","volume":"34","author":"T Kanda","year":"2016","unstructured":"Kanda, T., Oba, H., Toyoda, K., Kitajima, K. & Furui, S. Brain gadolinium deposition after administration of gadolinium-based contrast agents. Japanese J. Radiol. 34, 3\u20139 (2016).","journal-title":"Japanese J. Radiol."},{"key":"97943_CR16","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s10534-016-9931-7","volume":"29","author":"M Rogosnitzky","year":"2016","unstructured":"Rogosnitzky, M. & Branch, S. Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms. Biometals 29, 365\u2013376 (2016).","journal-title":"Biometals"},{"key":"97943_CR17","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1148\/radiol.212171","volume":"306","author":"N Hua","year":"2023","unstructured":"Hua, N. et al. Gadolinium deposition in the rat brain measured with quantitative MRI versus elemental mass spectrometry. Radiology 306, 244\u2013251 (2023).","journal-title":"Radiology"},{"key":"97943_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13244-019-0767-x","volume":"10","author":"A Splendiani","year":"2019","unstructured":"Splendiani, A. et al. Visible T1-hyperintensity of the dentate nucleus after multiple administrations of macrocyclic gadolinium-based contrast agents: yes or no? Insights into Imaging. 10, 1\u201310 (2019).","journal-title":"Insights into Imaging"},{"key":"97943_CR19","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.mri.2016.08.025","volume":"34","author":"N Murata","year":"2016","unstructured":"Murata, N., Murata, K., Gonzalez-Cuyar, L. F. & Maravilla, K. R. Gadolinium tissue deposition in brain and bone. Magn. Reson. Imaging. 34, 1359\u20131365 (2016).","journal-title":"Magn. Reson. Imaging"},{"key":"97943_CR20","first-page":"1097","volume":"10","author":"RC Semelka","year":"2023","unstructured":"Semelka, R. C. & Ramalho, M. Gadolinium deposition disease: current state of knowledge and expert opinion. Invest. Radiol. 10, 1097 (2023).","journal-title":"Invest. Radiol."},{"key":"97943_CR21","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/j.mri.2016.07.016","volume":"34","author":"RC Semelka","year":"2016","unstructured":"Semelka, R. C. et al. Gadolinium deposition disease: initial description of a disease that has been around for a while. Magn. Reson. Imaging. 34, 1383\u20131390 (2016).","journal-title":"Magn. Reson. Imaging"},{"key":"97943_CR22","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.mri.2016.05.005","volume":"34","author":"LM Burke","year":"2016","unstructured":"Burke, L. M. et al. Self-reported gadolinium toxicity: a survey of patients with chronic symptoms. Magn. Reson. Imaging. 34, 1078\u20131080 (2016).","journal-title":"Magn. Reson. Imaging"},{"key":"97943_CR23","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2214\/ajr.152.1.167","volume":"152","author":"R Weissleder","year":"1989","unstructured":"Weissleder, R. et al. Superparamagnetic iron oxide: pharmacokinetics and toxicity. Am. J. Roentgenol. 152, 167\u2013173 (1989).","journal-title":"Am. J. Roentgenol."},{"key":"97943_CR24","doi-asserted-by":"crossref","unstructured":"Estelrich, J., S\u00e1nchez-Mart\u00edn, M. J. & Busquets, M. A. Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents. Int. J. Nanomed. 10, 1727\u20131741 (2015).","DOI":"10.2147\/IJN.S76501"},{"key":"97943_CR25","doi-asserted-by":"publisher","first-page":"4902","DOI":"10.1038\/s41598-019-41277-z","volume":"9","author":"BW Stringer","year":"2019","unstructured":"Stringer, B. W. et al. A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastoma. Sci. Rep. 9, 4902 (2019).","journal-title":"Sci. Rep."},{"key":"97943_CR26","doi-asserted-by":"publisher","first-page":"6361","DOI":"10.7150\/thno.46468","volume":"10","author":"C Brighi","year":"2020","unstructured":"Brighi, C. et al. Comparative study of preclinical mouse models of high-grade glioma for nanomedicine research: the importance of reproducing blood-brain barrier heterogeneity. Theranostics 10, 6361 (2020).","journal-title":"Theranostics"},{"key":"97943_CR27","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/mrm.21478","volume":"60","author":"H Dahnke","year":"2008","unstructured":"Dahnke, H., Liu, W., Herzka, D., Frank, J. A. & Schaeffter, T. Susceptibility gradient mapping (SGM): a new postprocessing method for positive contrast generation applied to superparamagnetic iron oxide particle (SPIO)-labeled cells. Magn. Reson. Med. 60, 595\u2013603 (2008).","journal-title":"Magn. Reson. Med."},{"key":"97943_CR28","first-page":"445","volume":"60","author":"LP De Haro","year":"2015","unstructured":"De Haro, L. P. et al. Magnetic relaxometry as applied to sensitive cancer detection and localization. Biomedical Engineering\/Biomedizinische Technik. 60, 445\u2013455 (2015).","journal-title":"Biomedical Engineering\/Biomedizinische Technik"},{"key":"97943_CR29","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/cmmi.499","volume":"7","author":"NL Adolphi","year":"2012","unstructured":"Adolphi, N. L. et al. Imaging of Her2-targeted magnetic nanoparticles for breast cancer detection: comparison of SQUID\u2010detected magnetic relaxometry and MRI. Contrast Media Mol. Imaging. 7, 308\u2013319 (2012).","journal-title":"Contrast Media Mol. Imaging"},{"key":"97943_CR30","doi-asserted-by":"publisher","first-page":"eabb0998","DOI":"10.1126\/sciadv.abb0998","volume":"6","author":"DE Waddington","year":"2020","unstructured":"Waddington, D. E., Boele, T., Maschmeyer, R., Kuncic, Z. & Rosen, M. S. High-sensitivity in vivo contrast for ultra-low field magnetic resonance imaging using superparamagnetic iron oxide nanoparticles. Sci. Adv. 6, eabb0998 (2020).","journal-title":"Sci. Adv."},{"key":"97943_CR31","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1038\/s42003-024-06884-1","volume":"7","author":"S Shen","year":"2024","unstructured":"Shen, S. et al. Enhancing organ and vascular contrast in preclinical ultra-low field MRI using superparamagnetic iron oxide nanoparticles. Commun. Biology. 7, 1197 (2024).","journal-title":"Commun. Biology"},{"key":"97943_CR32","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.mattod.2022.04.001","volume":"56","author":"PA Chiarelli","year":"2022","unstructured":"Chiarelli, P. A. et al. Iron oxide nanoparticle-mediated radiation delivery for glioblastoma treatment. Mater. Today. 56, 66\u201378 (2022).","journal-title":"Mater. Today"},{"key":"97943_CR33","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nmeth.1455","volume":"7","author":"DJ Langford","year":"2010","unstructured":"Langford, D. J. et al. Coding of facial expressions of pain in the laboratory mouse. Nat. Methods. 7, 447\u2013449 (2010).","journal-title":"Nat. Methods"},{"key":"97943_CR34","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1097\/00004424-199506000-00008","volume":"30","author":"MF Tweedle","year":"1995","unstructured":"Tweedle, M. F., Wedeking, P. & Kumar, K. Biodistribution of radiolabeled, formulated gadopentetate, Gadoteridol, Gadoterate, and gadodiamide in mice and rats. Invest. Radiol. 30, 372\u2013380 (1995).","journal-title":"Invest. Radiol."},{"key":"97943_CR35","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0165-0270(02)00121-8","volume":"118","author":"JE Desmond","year":"2002","unstructured":"Desmond, J. E. & Glover, G. H. Estimating sample size in functional MRI (fMRI) neuroimaging studies: statistical power analyses. J. Neurosci. Methods. 118, 115\u2013128 (2002).","journal-title":"J. Neurosci. Methods"},{"key":"97943_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-9-465","volume":"9","author":"J Wang","year":"2009","unstructured":"Wang, J. et al. A reproducible brain tumour model established from human glioblastoma biopsies. BMC cancer. 9, 1\u201313 (2009).","journal-title":"BMC cancer"},{"key":"97943_CR37","doi-asserted-by":"publisher","first-page":"121416","DOI":"10.1016\/j.biomaterials.2022.121416","volume":"283","author":"PW Janowicz","year":"2022","unstructured":"Janowicz, P. W. et al. Understanding nanomedicine treatment in an aggressive spontaneous brain cancer model at the stage of early blood brain barrier disruption. Biomaterials 283, 121416 (2022).","journal-title":"Biomaterials"},{"key":"97943_CR38","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.kint.2016.12.037","volume":"92","author":"GB Toth","year":"2017","unstructured":"Toth, G. B. et al. Current and potential imaging applications of Ferumoxytol for magnetic resonance imaging. Kidney Int. 92, 47\u201366 (2017).","journal-title":"Kidney Int."},{"key":"97943_CR39","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/RLI.0000000000000434","volume":"53","author":"G Knobloch","year":"2018","unstructured":"Knobloch, G. et al. Relaxivity of Ferumoxytol at 1.5 T and 3.0 T. Invest. Radiol. 53, 257\u2013263 (2018).","journal-title":"Invest. Radiol."},{"key":"97943_CR40","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1007\/s00330-005-0031-2","volume":"16","author":"GH Simon","year":"2006","unstructured":"Simon, G. H. et al. T1 and T2 relaxivity of intracellular and extracellular USPIO at 1.5 T and 3T clinical MR scanning. Eur. Radiol. 16, 738\u2013745 (2006).","journal-title":"Eur. Radiol."},{"key":"97943_CR41","doi-asserted-by":"publisher","first-page":"2000153","DOI":"10.1002\/smll.202000153","volume":"16","author":"A Boey","year":"2020","unstructured":"Boey, A. & Ho, H. K. All roads lead to the liver: metal nanoparticles and their implications for liver health. Small 16, 2000153 (2020).","journal-title":"Small"},{"key":"97943_CR42","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1021\/acsnano.9b06071","volume":"14","author":"NJ Hunt","year":"2020","unstructured":"Hunt, N. J. et al. Rapid intestinal uptake and targeted delivery to the liver endothelium using orally administered silver sulfide quantum Dots. ACS Nano. 14, 1492\u20131507 (2020).","journal-title":"ACS Nano"},{"key":"97943_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-022-01479-6","volume":"20","author":"D Zhuang","year":"2022","unstructured":"Zhuang, D., Zhang, H., Hu, G. & Guo, B. Recent development of contrast agents for magnetic resonance and multimodal imaging of glioblastoma. J. Nanobiotechnol. 20, 1\u201321 (2022).","journal-title":"J. Nanobiotechnol."},{"key":"97943_CR44","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/j.1365-2990.2004.00557.x","volume":"30","author":"EA Neuwelt","year":"2004","unstructured":"Neuwelt, E. A. et al. Imaging of iron oxide nanoparticles by MR and light microscopy in patients with malignant brain tumours. Neuropathol. Appl. Neurobiol. 30, 456\u2013471 (2004).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"97943_CR45","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.3174\/ajnr.A6600","volume":"41","author":"R Barajas","year":"2020","unstructured":"Barajas, R. et al. Distinguishing extravascular from intravascular Ferumoxytol pools within the brain: proof of concept in patients with treated glioblastoma. Am. J. Neuroradiol. 41, 1193\u20131200 (2020).","journal-title":"Am. J. Neuroradiol."},{"key":"97943_CR46","doi-asserted-by":"crossref","unstructured":"Wongsawaeng, D. et al. Comparison of dynamic susceptibility contrast (DSC) using gadolinium and iron-based contrast agents in high-grade glioma at high-field MRI. Neuroradiol. J. 37, 473\u2013482 (2024).","DOI":"10.1177\/19714009241242596"},{"key":"97943_CR47","doi-asserted-by":"publisher","unstructured":"Bobholz, S. A. et al. Multi-Site retrospective analysis of diffusion and perfusion MRI correlates to glioma characteristics derived from Radio-Pathomic maps. Neuro-Oncology, noaf044. https:\/\/doi.org\/10.1093\/neuonc\/noaf044 (2025).","DOI":"10.1093\/neuonc\/noaf044"},{"key":"97943_CR48","doi-asserted-by":"publisher","first-page":"7559","DOI":"10.1039\/C9RA10969B","volume":"10","author":"T Liu","year":"2020","unstructured":"Liu, T. et al. The effect of size and surface ligands of iron oxide nanoparticles on blood compatibility. RSC Adv. 10, 7559\u20137569 (2020).","journal-title":"RSC Adv."},{"key":"97943_CR49","doi-asserted-by":"publisher","first-page":"3040","DOI":"10.1039\/C7NR00089H","volume":"9","author":"H Zhou","year":"2017","unstructured":"Zhou, H. et al. In vivo aggregation-induced transition between T 1 and T 2 relaxations of magnetic ultra-small iron oxide nanoparticles in tumor microenvironment. Nanoscale 9, 3040\u20133050 (2017).","journal-title":"Nanoscale"},{"key":"97943_CR50","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1021\/jacs.0c10245","volume":"143","author":"H Zhou","year":"2021","unstructured":"Zhou, H. et al. Hypoxia-triggered self-assembly of ultrasmall iron oxide nanoparticles to amplify the imaging signal of a tumor. J. Am. Chem. Soc. 143, 1846\u20131853 (2021).","journal-title":"J. Am. Chem. Soc."},{"key":"97943_CR51","doi-asserted-by":"publisher","first-page":"rbab062","DOI":"10.1093\/rb\/rbab062","volume":"8","author":"Z Wu","year":"2021","unstructured":"Wu, Z. et al. Advances in magnetic resonance imaging contrast agents for glioblastoma-targeting theranostics. Regenerative Biomaterials. 8, rbab062 (2021).","journal-title":"Regenerative Biomaterials"},{"key":"97943_CR52","doi-asserted-by":"publisher","first-page":"6169","DOI":"10.1021\/acs.molpharmaceut.3c00558","volume":"20","author":"M Lim","year":"2023","unstructured":"Lim, M. et al. Targeted hyperbranched nanoparticles for delivery of doxorubicin in breast cancer brain metastasis. Mol. Pharm. 20, 6169\u20136183 (2023).","journal-title":"Mol. Pharm."},{"key":"97943_CR53","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.2217\/nnm.15.22","volume":"10","author":"OL Gobbo","year":"2015","unstructured":"Gobbo, O. L. et al. Biodistribution and Pharmacokinetic studies of SPION using particle electron paramagnetic resonance, MRI and ICP-MS. Nanomedicine 10, 1751\u20131760 (2015).","journal-title":"Nanomedicine"},{"key":"97943_CR54","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3390\/ijms19010205","volume":"19","author":"BT Pham","year":"2018","unstructured":"Pham, B. T. et al. Biodistribution and clearance of stable superparamagnetic maghemite iron oxide nanoparticles in mice following intraperitoneal administration. Int. J. Mol. Sci. 19, 205 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"97943_CR55","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/mrm.22241","volume":"63","author":"T \u00c7ukur","year":"2010","unstructured":"\u00c7ukur, T., Yamada, M., Overall, W. R., Yang, P. & Nishimura, D. G. Positive contrast with alternating repetition time SSFP (PARTS): A fast imaging technique for SPIO-labeled cells. Magn. Reson. Medicine: Official J. Int. Soc. Magn. Reson. Med. 63, 427\u2013437 (2010).","journal-title":"Magn. Reson. Medicine: Official J. Int. Soc. Magn. Reson. Med."},{"key":"97943_CR56","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1155\/2012\/734842","volume":"2012","author":"C Lin","year":"2012","unstructured":"Lin, C., Cai, S. & Feng, J. Positive contrast imaging of SPIO nanoparticles. J. Nanomaterials. 2012, 6\u20136 (2012).","journal-title":"J. Nanomaterials"},{"key":"97943_CR57","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.biomaterials.2010.09.024","volume":"32","author":"H Xie","year":"2011","unstructured":"Xie, H. et al. Lactoferrin-conjugated superparamagnetic iron oxide nanoparticles as a specific MRI contrast agent for detection of brain glioma in vivo. Biomaterials 32, 495\u2013502 (2011).","journal-title":"Biomaterials"},{"key":"97943_CR58","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1148\/radiol.11110251","volume":"262","author":"T Liu","year":"2012","unstructured":"Liu, T. et al. Cerebral microbleeds: burden assessment by using quantitative susceptibility mapping. Radiology 262, 269\u2013278 (2012).","journal-title":"Radiology"},{"key":"97943_CR59","doi-asserted-by":"publisher","first-page":"5072","DOI":"10.3390\/molecules25215072","volume":"25","author":"X Li","year":"2020","unstructured":"Li, X., Sun, Y., Ma, L., Liu, G. & Wang, Z. The renal clearable magnetic resonance imaging contrast agents: state of the Art and recent advances. Molecules 25, 5072 (2020).","journal-title":"Molecules"},{"key":"97943_CR60","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3348\/kjr.2018.0356","volume":"20","author":"JW Choi","year":"2019","unstructured":"Choi, J. W. & Moon, W. J. Gadolinium deposition in the brain: current updates. Korean J. Radiol. 20, 134\u2013147 (2019).","journal-title":"Korean J. Radiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97943-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97943-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97943-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T07:02:45Z","timestamp":1745478165000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97943-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["97943"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-97943-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.02.02.635583","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,24]]},"assertion":[{"value":"22 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"DEJW, CB and ZK have received research support from Imagion Biosystems Inc. and Patrys. MZ is an employee of Imagion Biosystems Inc. All the remaining authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14283"}}